In vitro experiments indicated that COX-2 was highly expressed in esophageal cancer [24], liver cancer [25], and endometrial cancer [26] and that a higher COX-2 level resulted in higher cell proliferation. This evidence concerns the gene PTGS2 and esophageal cancer.